Rating History for Moonlake Immunotherapeutics (MLTX) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/23/2026 | Andy Chen | Upgrade | Outperform (Peerperform) |
24.00 (12.00) |
16.27 (19.21) |
18.07% | Details |
 |
|||||||
|
|||||||
|
|||||||
